What have pharmacies paid for Naltrexone since 2013?
What pharmacies pay, not what you pay. Naltrexone has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Naltrexone 50 MG Tablet: $1.02 per unit at the 2013 survey and $1.12 at 2026 (+10%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Naltrexone1 product in NADAC
1product with a price history
Naltrexone has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
Between each product's first and latest year-end survey, no product costs pharmacies less and 1 product costs more, by more than 5 percent, per unit as CMS states it.
This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.
Naltrexone 50 MG Tablet
Generic
$1.02 per unit at the 2013 year-end survey (11 NDCs) and $1.12 at the 2026 survey (21 NDCs): +10%.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2013 (2013-12-25)
$1.02
11
2014 (2014-12-31)
$0.916
13
2015 (2015-12-30)
$0.933
14
2016 (2016-12-28)
$0.883
14
2017 (2017-12-27)
$0.797
12
2018 (2018-12-26)
$0.733
12
2019 (2019-12-25)
$0.779
12
2020 (2020-12-30)
$0.799
13
2021 (2021-12-29)
$0.770
13
2022 (2022-12-28)
$0.645
15
2023 (2023-12-27)
$0.883
14
2024 (2024-12-25)
$0.985
19
2025 (2025-12-31)
$1.26
21
2026 (2026-11-11)
$1.12
21
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
How many companies make Naltrexone?
The FDA Orange Book lists no generic maker as marketed for Naltrexone, and the first generic approval is dated 6 July 2023. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.